Algin and Abacavir drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Algin and Abacavir. Common interactions include viral load increased among males.
The phase IV clinical study analyzes what interactions people who take Algin and Abacavir have. It is created by eHealthMe based on reports of 8 people who take Algin and Abacavir from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
8 people who take Algin and Abacavir together, and have interactions are studied.
What is Algin?
Algin has active ingredients of algin. eHealthMe is studying from 1,257 Algin users for its effectiveness, alternative drugs and more.
What is Abacavir?
Abacavir has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 7,904 Abacavir users for its effectiveness, alternative drugs and more.
Number of Algin and Abacavir reports submitted per year:
Common Algin and Abacavir drug interactions by gender *:
- Viral load increased
Common Algin and Abacavir drug interactions by age *:
- Viral load increased
* Approximation only. Some reports may have incomplete information.
Do you take Algin and Abacavir?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Algin and Abacavir:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Abacavir side effects:
- Fever: 655 reports
- Indigestion: 548 reports
- Rashes (redness): 333 reports
- Diarrhea: 328 reports
- Fatigue (feeling of tiredness): 322 reports
- Weakness: 281 reports
Browse all side effects of Abacavir:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Algin interactions:
- Algin and Lansoprazole: 309 reports
- Algin and Paracetamol: 245 reports
- Algin and Omeprazole: 236 reports
- Algin and Prednisolone: 140 reports
- Algin and Furosemide: 135 reports
- Algin and Amlodipine: 124 reports
- Algin and Ramipril: 104 reports
Browse all interactions between Algin and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Abacavir interactions:
- Abacavir and Lamivudine: 2,153 reports
- Abacavir and Efavirenz: 1,694 reports
- Abacavir and Nevirapine: 1,302 reports
- Abacavir and Didanosine: 1,293 reports
- Abacavir and Stavudine: 1,163 reports
- Abacavir and Kaletra: 1,158 reports
- Abacavir and Ritonavir: 1,148 reports
- Abacavir and Norvir: 775 reports
- Abacavir and Zidovudine: 742 reports
- Abacavir and Tenofovir disoproxil fumarate: 735 reports
Browse all interactions between Abacavir and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on algin and abacavir sulfate (the active ingredients of Algin and Abacavir, respectively), and Algin and Abacavir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Algin and Abacavir.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Clopidogrel and Lupron drug interaction - a second ago
- Acyclovir and Glossitis - 2 seconds ago
- Coronary Artery Disease Aggravated and Intracranial Tumor Haemorrhage - 6 seconds ago
- Fluvastatin and Idiopathic Pulmonary Fibrosis - 7 seconds ago
- Percocet and Tachypnea - 9 seconds ago
- Vascular Anomaly and drugs of ingredients of metoclopramide hydrochloride - 10 seconds ago
- Actigall and Neurontin drug interaction - 12 seconds ago
- Aromasin and Kytril drug interaction - 14 seconds ago
- Rayos vs. Methotrexate - 15 seconds ago
- Tranexamic Acid and Xtandi drug interaction - 18 seconds ago